Last updated Tuesday June 15, 2021 at 4:30 PM EDT
This page will be kept to-up-date with information regarding the review status for all risk levels, in order to provide the research community with information on what the Face-to-Face COVID-19 Review Committee (F2FCRC) and the University’s Research Ethics Boards (REBs) are able to review at any given time.
As of June 11, 2021, the F2FCRC and REBs are accepting all levels of face-to-face research for review. Approvals are contingent on current public health measures.
The table below indicates the approximate point when research at a given COVID-19 Research Risk Level may start.
New COVID-19 research or new F2F research where the participant is receiving a service that would be delivered/received regardless of the research (e.g. clinical care) and researchers currently in other regions or countries where public health directives allow for F2F research can commence these projects immediately upon approval of the F2FCRC and REB.
Ongoing research in another country or region may continue in accordance with local public health directives.
|COVID-19 Research Risk||Research Method||Direct contact / close contact?||Approximate start (Provincial Roadmap)|
|Level 1||Interaction / observation||None or minimal contact, physical distancing can be easily achieved (e.g., interviews, computer-based experiments, non-invasive methods)||Step 1|
|Level 2||Intervention||Some physical contact (e.g., biospecimen collection, body measurements), physical distancing sometimes challenging to maintain||Step 1|
|Level 3||Physical treatment / manipulation||Sustained physical contact, participant breathing heavily, physical distancing not possible||Step 2-3|
Please note: Human research that can be done through virtual (e.g. Microsoft Teams, Zoom), remote (e.g. phone, email) or online (e.g. MTurk, REDCap) methods should be conducted through these methods.
- Researchers proposing F2F research will complete the Face-to-Face and Off-Campus COVID-19 (F2FOC) Review form, and upload the provided PDF copy of the completed form to the Documents Summary (Section #13) of their My Research Human Protocols (MRHP) new submission or amendment.
- The F2FCRC will review the form and provide recommendations to the vice-deans/associate deans/vice-principals (research) and researchers on the project’s risks and health and safety requirements. If further information is required, a member the F2FCRC will reach out to the Principal Investigator directly.
- The REB will conduct an ethics review of the protocol, as per normal requirements. Once the protocol is approved, the Principal Investigator will receive notification of REB approval. This is not sufficient to commence F2F research.
- Once both the F2FCRC and the REB approve the study and the research can start per the F2F Research Roadmap (above), an F2FCRC approval letter will be issued to the Principal Investigator to allow them to start or resume their study.
As study submissions must be reviewed by both the REB and the F2FCRC before they can proceed, review times may be longer than normal.
Details on this new institutional process can be found on the Review of Face-to-Face and Off-Campus Research page.
Please direct your questions about this process to email@example.com.